The Critical Path Institute (C-Path), a public-private partnership, has appointed Klaus Romero as chief executive officer and promoted Cécile Ollivier to vice president of global affairs. Dr Romero has worked over 16 years at C-Path in several positions supporting its initiatives in drug development. Ms Ollivier joined C-Path as managing director, Europe in April 2021. In her new role she will focus on international collaborations. She has more than 16 years’ experience in the healthcare sector, making contributions to paediatric and rare disease drug development at organisations including the European Medicines Agency.
C-Path announced the appointments on 25 January 2024.
Copyright 2024 Evernow Publishing Ltd